“Efficacy and Safety of Long-Term Tildrakizumab for Plaque Psoriasis: 4-Year Results from Resurface 1 and Resurface 2”. SKIN The Journal of Cutaneous Medicine 4, no. 5 (September 2, 2020): s39. Accessed April 19, 2026. https://skin.dermsquared.com/skin/article/view/988.